Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 3
2018 2
2019 2
2020 1
2021 13
2022 13
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
CD24: A Novel Target for Cancer Immunotherapy.
Panagiotou E, Syrigos NK, Charpidou A, Kotteas E, Vathiotis IA. Panagiotou E, et al. Among authors: syrigos nk. J Pers Med. 2022 Jul 28;12(8):1235. doi: 10.3390/jpm12081235. J Pers Med. 2022. PMID: 36013184 Free PMC article. Review.
Malignant Superior Vena Cava Syndrome: State of the Art.
Patriarcheas V, Grammoustianou M, Ptohis N, Thanou I, Kostis M, Gkiozos I, Charpidou A, Trontzas I, Syrigos N, Kotteas E, Dimakakos E. Patriarcheas V, et al. Among authors: syrigos n. Cureus. 2022 Jan 4;14(1):e20924. doi: 10.7759/cureus.20924. eCollection 2022 Jan. Cureus. 2022. PMID: 35004083 Free PMC article. Review.
The Role of REV-ERB Receptors in Cancer Pathogenesis.
Gomatou G, Karachaliou A, Veloudiou OZ, Karvela A, Syrigos N, Kotteas E. Gomatou G, et al. Among authors: syrigos n. Int J Mol Sci. 2023 May 19;24(10):8980. doi: 10.3390/ijms24108980. Int J Mol Sci. 2023. PMID: 37240325 Free PMC article. Review.
Progress and Challenges of Messenger RNA Vaccines in the Therapeutics of NSCLC.
Kiousi E, Lyraraki V, Mardiki GL, Stachika N, Damianou AK, Malainou CP, Syrigos N, Gomatou G, Kotteas E. Kiousi E, et al. Among authors: syrigos n. Cancers (Basel). 2023 Nov 26;15(23):5589. doi: 10.3390/cancers15235589. Cancers (Basel). 2023. PMID: 38067293 Free PMC article. Review.
Orbital metastases of invasive lobular breast carcinoma.
Tsagkaraki IM, Kourouniotis CD, Gomatou GL, Syrigos NK, Kotteas EA. Tsagkaraki IM, et al. Among authors: syrigos nk. Breast Dis. 2019;38(3-4):85-91. doi: 10.3233/BD-190398. Breast Dis. 2019. PMID: 31640079 Review.
Emerging therapies in thymic epithelial tumors (Review).
Dapergola A, Gomatou G, Trontzas I, Panagiotou E, Dimakakos E, Syrigos N, Kotteas E. Dapergola A, et al. Among authors: syrigos n. Oncol Lett. 2023 Jan 16;25(2):84. doi: 10.3892/ol.2023.13670. eCollection 2023 Feb. Oncol Lett. 2023. PMID: 36760515 Free PMC article. Review.
Tumor Dormancy: Implications for Invasion and Metastasis.
Gomatou G, Syrigos N, Vathiotis IA, Kotteas EA. Gomatou G, et al. Among authors: syrigos n. Int J Mol Sci. 2021 May 4;22(9):4862. doi: 10.3390/ijms22094862. Int J Mol Sci. 2021. PMID: 34064392 Free PMC article. Review.
The role of kisspeptin system in cancer biology.
Stathaki M, Stamatiou ME, Magioris G, Simantiris S, Syrigos N, Dourakis S, Koutsilieris M, Armakolas A. Stathaki M, et al. Among authors: syrigos n. Crit Rev Oncol Hematol. 2019 Oct;142:130-140. doi: 10.1016/j.critrevonc.2019.07.015. Epub 2019 Aug 3. Crit Rev Oncol Hematol. 2019. PMID: 31401420 Review.
Mechanisms of resistance to cyclin-dependent kinase 4/6 inhibitors.
Gomatou G, Trontzas I, Ioannou S, Drizou M, Syrigos N, Kotteas E. Gomatou G, et al. Among authors: syrigos n. Mol Biol Rep. 2021 Jan;48(1):915-925. doi: 10.1007/s11033-020-06100-3. Epub 2021 Jan 7. Mol Biol Rep. 2021. PMID: 33409716 Review.
42 results